1 min read
Add as a preferred source on GoogleEvonik Posts 13% Q3 Sales Gain, Its Strongest Since Q3 2022
Evonik said a result in the upper half of its €2 billion to €2.2 billion adjusted EBITDA range for 2026 now seems likely.
Evonik Industries AG’s third-quarter sales rose 13% year over year, its strongest quarterly gain since Q3 2022, while Evonik said a result in the upper half of its 2026 adjusted EBITDA range now seems likely.
The range is €2 billion to €2.2 billion.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.